TCI Wealth Advisors’s GenMark Diagnostics, Inc GNMK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-171
| Closed | -$4K | – | 2546 |
|
|
2021
Q1 | $4K | Sell |
171
-6,640
| -97% | -$123K | ﹤0.01% | 1466 |
|
|
2020
Q4 | $99K | Hold |
6,811
| – | – | 0.04% | 232 |
|
|
2020
Q3 | $97K | Hold |
6,811
| – | – | 0.04% | 217 |
|
|
2020
Q2 | $100K | Hold |
6,811
| – | – | 0.04% | 210 |
|
|
2020
Q1 | $28K | Hold |
6,811
| – | – | 0.01% | 407 |
|
|
2019
Q4 | $33K | Hold |
6,811
| – | – | 0.01% | 462 |
|
|
2019
Q3 | $41K | Hold |
6,811
| – | – | 0.02% | 362 |
|
|
2019
Q2 | $44K | Hold |
6,811
| – | – | 0.02% | 336 |
|
|
2019
Q1 | $48K | Hold |
6,811
| – | – | 0.02% | 346 |
|
|
2018
Q4 | $33K | Hold |
6,811
| – | – | 0.02% | 386 |
|
|
2018
Q3 | $50K | Hold |
6,811
| – | – | 0.02% | 343 |
|
|
2018
Q2 | $43K | Hold |
6,811
| – | – | 0.02% | 352 |
|
|
2018
Q1 | $37K | Hold |
6,811
| – | – | 0.02% | 375 |
|
|
2017
Q4 | $28K | Hold |
6,811
| – | – | 0.01% | 437 |
|
|
2017
Q3 | $66K | Sell |
6,811
-198
| -3% | -$2.06K | 0.03% | 276 |
|
|
2017
Q2 | $83K | Hold |
7,009
| – | – | 0.04% | 228 |
|
|
2017
Q1 | $90K | Hold |
7,009
| – | – | 0.05% | 224 |
|
|
2016
Q4 | $86K | Hold |
7,009
| – | – | 0.05% | 244 |
|
|
2016
Q3 | $83K | Hold |
7,009
| – | – | 0.05% | 235 |
|
|
2016
Q2 | $61K | Sell |
7,009
-1,019
| -13% | -$6.99K | 0.03% | 273 |
|
|
2016
Q1 | $42K | Hold |
8,028
| – | – | 0.02% | 323 |
|
|
2015
Q4 | $62K | Hold |
8,028
| – | – | 0.03% | 276 |
|
|
2015
Q3 | $63K | Buy |
8,028
+2,000
| +33% | +$18.5K | 0.04% | 251 |
|
|
2015
Q2 | $55K | Sell |
6,028
-110
| -2% | -$1.11K | 0.03% | 274 |
|
|
2015
Q1 | $80K | Buy |
6,138
+110
| +2% | +$1.44K | 0.05% | 194 |
|
|
2014
Q4 | $82K | Hold |
6,028
| – | – | 0.05% | 196 |
|
|
2014
Q3 | $54K | Hold |
6,028
| – | – | 0.03% | 233 |
|
|
2014
Q2 | $82K | Hold |
6,028
| – | – | 0.05% | 203 |
|
|
2014
Q1 | $60K | Hold |
6,028
| – | – | 0.04% | 216 |
|
|
2013
Q4 | $80K | Hold |
6,028
| – | – | 0.05% | 188 |
|
|
2013
Q3 | $73K | Hold |
6,028
| – | – | 0.06% | 178 |
|
|
2013
Q2 | $62K | Buy |
+6,028
| New | +$83.1K | 0.05% | 203 |
|
TCI Wealth Advisors's GNMK Position: Q2 2021 in Review
TCI Wealth Advisors sold out of GenMark Diagnostics, Inc (GNMK) in Q2 2021, closing a stake of 171 shares — an estimated $4K sold.
TCI Wealth Advisors first reported a position in GNMK in Q2 2013 and held it in 32 quarters. The position peaked at $100K in Q2 2020. 0 funds tracked by Wall St. Rank hold GNMK as of Q2 2021.
- TCI Wealth Advisors reported no remaining GenMark Diagnostics, Inc position as of Q2 2021 after selling out during the quarter.
- TCI Wealth Advisors sold 171 GenMark Diagnostics, Inc shares in Q2 2021, an estimated $4K.
- TCI Wealth Advisors first reported a position in GenMark Diagnostics, Inc in Q2 2013 and held it in 32 quarters.
- TCI Wealth Advisors's GenMark Diagnostics, Inc position peaked at $100K in Q2 2020.
- 0 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q2 2021.
Based on TCI Wealth Advisors's 13F filing for Q2 2021, filed 2 Aug 2021.